Preview

Yakut Medical Journal

Advanced search

Evaluation of antitumor activity of benzimidazole derivative on models of experimental tumors

https://doi.org/10.1234/YMJ.2022.77.06

Abstract

The effect of dihydrobromide-2-(3,4-dihydroxyphenyl)-9-diethylamino-ethylimidazo-[1,2-a] benzimidazole on the growth and metastasis of transplanted allografts of melanoma B16 and epidermoid lung carcinoma Lewis with intraperitoneal administration was investigated. The antitumor effect was established in relation to primary epidermoid lung carcinoma by Lewis and its metastases to the lungs, as well as in relation to metastatic lung damage for melanoma B16 mice.

About the Authors

O. I. Kit
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Oleg I. Kit – MD, Prof., Member-cor. RAS, General Director.

Rostov-on-Don



E. F. Komarova
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Ekaterina F. Komarova – associate researcher, Doctor of Biological Sciences, Head of the Department of the Rostov State Medical University, Ministry of Health of the Russian Federation, associate researcher of the NMRC of Oncology of the Ministry of Health RF.

Rostov-on-Don



E. V. Verenikina
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Ekaterina V. Verenikina – MD, head of the department.

Rostov-on-Don



A. Yu. Maksimov
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Alexey Yu. Maksimov – MD, Professor, Deputy General Director for Advanced Scientific Research.

Rostov-on-Don



A. S. Morkovnik
Southern Federal University
Russian Federation

Anatoly S. Morkovnik – Doctor of Chemical Sciences, Head of Scientific Research Institute.

Rostov-on-Don



O. N. Zhukovskaya
Southern Federal University
Russian Federation

Olga N. Zhukovskaya – Candidate of Chemical Sciences, Senior Researcher, Research Institute of Physical and Organic Chemistry of the Southern Federal University.

Rostov-on-Don



A. S. Goncharova
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Anna S. Goncharova – Candidate of Biological Sciences, head, Testing laboratory center.

Rostov-on-Don



N. A. Shevchenko
Rostov State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Natalia A. Shevchenko – postgraduate student of the Rostov State Medical University of the Ministry of Health of the Russian Federation.



S. N. Vlasov
Rostov State Medical University of the Ministry of Health of the Russian Federation
Russian Federation

Sergey N. Vlasov – student of the Rostov State Medical University of the Ministry of Health of the Russian Federation.



E. V. Zaikina
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Ekaterina V. Zaikina – junior researcher of the Testing Laboratory Center.

Rostov-on-Don



L. Z. Kurbanova
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Luisa Z. Kurbanova – junior researcher of the Testing Laboratory Center.

Rostov-on-Don



D. V. Khodakova
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Darya V. Khodakova – junior researcher of the Testing Laboratory Center.

Rostov-on-Don



O. V. Pandova
NMRC of Oncology, Ministry of Health of the Russian Federation
Russian Federation

Olga V. Pandova – Candidate of Medical Sciences, neurologist.

Rostov-on-Don



References

1. Adoptive cell therapy: current advances / Shamova T.V. [et al]. // South Russian Journal of Cancer. 2020;1(1):43-59. DOI: 10.37748/2687-0533-2020-1-1-4

2. Kit O.I. Neuroendocrine, clinical and morphological aspects of gastric cancer. Novocherkassk, 2014.

3. Mironov A.N. Guidelines for conducting preclinical trials of medicines. – 2012.

4. Assessment of antitumor activity of enoxifol antioxidant on B16 melanoma model in experiment/ E.F. Komarova [et al]. // Proceedings of universities. North Caucasian region. Natural Sciences. – 2017. - №. 3-2 (195-2).

5. Benzimidazole derivative as antitumor drug against experimentally induced lung carcinoma/ E.F. Komarova [et al]. DOI: 10.24075/brsmu.2021.031

6. Benzimidazole scaffolds as promising antiproliferative agents: a review/ Tahlan S. [et al]. // BMC chemistry. – 2019. – V. 13, №. 1. – P. 1-16. DOI:10.1186/s13065-019-0579-6

7. Common pathogenic mechanisms between idiopathic pulmonary fibrosis and lung cancer/ Tzouvelekis A. [et al]. //Chest. – 2019. – V. 156, № 2. – P. 383-391.

8. Discovery of the poly (ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1 H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer/ Penning T.D. [et al.] //Journal of medicinal chemistry. – 2009. – V. 52, №. 2. – P. 514-523.

9. El Rashedy A.A., Aboul-Enein H. Y. Benzimidazole derivatives as potential anticancer agents //Mini reviews in medicinal chemistry. – 2013. – V. 13, №. 3. – P. 399-407. DOI: 10.2174/138955713804999847

10. Evaluation of the anticancer activities of novel transition metal complexes with berenil and nitroimidazole/ Czarnomysy R. [et al]. //Molecules. – 2020. – V. 25, №. 12. – P. 2860. DOI: 10.3390/molecules25122860.

11. Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications/ Wei Q. [et al.] // Oncogene. 2020; 39 (39): 6139–56.

12. Mierke C.T. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells //Reports on Progress in Physics. – 2019. – V. 82, №. 6. – P. 064602.

13. Mitochondrial oxidative phosphorylation in cutaneous melanoma/ Kumar P.R. [et al.] // Br J Cancer. 2021 Jan;124(1):115-123. doi: 10.1038/s41416-020-01159-y.

14. Neagu M. Metabolic Traits in Cutaneous Melanoma // Front Oncol. 2020 May 19;10:851. doi: 10.3389/fonc.2020.00851.

15. Ohshima K, Morii E. Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis // Metabolites. 2021; 11 (1): 28.

16. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma/ Cecconi D. [et al.] //Scientific reports. – 2019. – V. 9, №. 1. – С. 1-12.

17. The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism / Vanhove K. [et al.] // Front Oncol. 2019 Nov 15;9:1215. doi: 10.3389/fonc.2019.01215.


Review

For citations:


Kit O.I., Komarova E.F., Verenikina E.V., Maksimov A.Yu., Morkovnik A.S., Zhukovskaya O.N., Goncharova A.S., Shevchenko N.A., Vlasov S.N., Zaikina E.V., Kurbanova L.Z., Khodakova D.V., Pandova O.V. Evaluation of antitumor activity of benzimidazole derivative on models of experimental tumors. Yakut Medical Journal. 2022;(1):23-26. https://doi.org/10.1234/YMJ.2022.77.06

Views: 62


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1813-1905 (Print)
ISSN 2312-1017 (Online)